{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:36:45Z","timestamp":1773419805457,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jocd.2012.11.003","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T02:04:21Z","timestamp":1359597861000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Hereditary Hyperparathyroidism Syndromes"],"prefix":"10.1016","volume":"16","author":[{"given":"Francesca","family":"Giusti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7 Suppl","key":"10.1016\/j.jocd.2012.11.003_bib1","first-page":"40","article-title":"Sporadic and hereditary primary hyperparathyroidism","volume":"34","author":"Pepe","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2012.11.003_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.jocd.2012.11.003_bib3","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2012.11.003_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.14310\/horm.2002.1325","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature","volume":"10","author":"Del Pozo","year":"2011","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jocd.2012.11.003_bib5","series-title":"GeneReviews at GeneTests: Medical Genetics Information Resource [database online]","article-title":"Multiple endocrine neoplasia type 1","author":"Falchetti","year":"1997-2005"},{"key":"10.1016\/j.jocd.2012.11.003_bib6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","article-title":"Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple neoplasia type 1?","volume":"246","author":"Tonelli","year":"2007","journal-title":"Ann Surg"},{"issue":"5311","key":"10.1016\/j.jocd.2012.11.003_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jocd.2012.11.003_bib8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jocd.2012.11.003_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"16","key":"10.1016\/j.jocd.2012.11.003_bib10","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1158\/0008-5472.CAN-09-0678","article-title":"Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis","volume":"69","author":"Gracanin","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.003_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncpendmet0816","article-title":"A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet","volume":"4","author":"Falchetti","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.003_bib12","doi-asserted-by":"crossref","first-page":"906163","DOI":"10.1155\/2010\/906163","article-title":"Clinical use of cinacalcet in MEN1 hyperparathyroidism","volume":"2010","author":"Moyes","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"5","key":"10.1016\/j.jocd.2012.11.003_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2265.2008.03301.x","article-title":"Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients","volume":"69","author":"Faggiano","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jocd.2012.11.003_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0002-9343(62)90126-2","article-title":"Familial endocrine tumors: report of two unrelated kindreds affected with pheochromocytomas, one also with multiple thyroid carcinomas","volume":"32","author":"Cushman","year":"1962","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jocd.2012.11.003_bib15","first-page":"487","article-title":"Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs \u00e0 Calcitonine","volume":"83","author":"Schuffenecker","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2012.11.003_bib16","first-page":"141","article-title":"Hereditary hyperparathyroidism","volume":"3","author":"Falchetti","year":"2006","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.003_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.jocd.2012.11.003_bib18","first-page":"333","article-title":"Role of menin in the regulation of telomerase activity in normal and cancer cells","volume":"33","author":"Hashimoto","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jocd.2012.11.003_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jocd.2012.11.003_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2005.10.028","article-title":"Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside","volume":"247","author":"Machens","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.003_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.2009.02105.x","article-title":"DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes","volume":"266","author":"Falchetti","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.jocd.2012.11.003_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archsurg.138.4.409","article-title":"Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship","volume":"138","author":"Yip","year":"2003","journal-title":"Arch Surg"},{"key":"10.1016\/j.jocd.2012.11.003_bib23","first-page":"3048","article-title":"Recessive transmission of a multiple endocrine neoplasia syndrome in the rat","volume":"62","author":"Fritz","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocd.2012.11.003_bib24","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27(Kip1) cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.jocd.2012.11.003_bib25","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline cdkn1b\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.003_bib26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.003_bib27","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A novel germline cdkn1b mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jocd.2012.11.003_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000320366","article-title":"p27kip1: A new multiple endocrine neoplasia gene?","volume":"93","author":"Marinoni","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jocd.2012.11.003_bib29","first-page":"5441","article-title":"Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27","volume":"57","author":"Katayose","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocd.2012.11.003_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I","article-title":"Regulation of the CDK inhibitor\u00a0p27 and its deregulation in cancer","volume":"183","author":"Slingerland","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jocd.2012.11.003_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","article-title":"The CDK inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy","volume":"8","author":"Chu","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jocd.2012.11.003_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-11-0929","article-title":"Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1(CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jocd.2012.11.003_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-3476(72)80232-4","article-title":"Familial benign hypercalcemia","volume":"81","author":"Foley","year":"1972","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jocd.2012.11.003_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0002-9343(77)90873-7","article-title":"Family studies in patients with primary parathyroid hyperplasia","volume":"62","author":"Marx","year":"1977","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.003_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-198111000-00002","article-title":"The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds","volume":"60","author":"Marx","year":"1981","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.jocd.2012.11.003_bib36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2265.1985.tb01110.x","article-title":"Familial hypocalciuric hypercalcaemia. II. Intestinal calcium absorption and vitamin D metabolism","volume":"23","author":"Kristiansen","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jocd.2012.11.003_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-8529(18)30362-1","article-title":"Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism","volume":"18","author":"Heath","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.003_bib38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jbspin.2009.02.001","article-title":"Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis","volume":"76","author":"Volpe","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"14","key":"10.1016\/j.jocd.2012.11.003_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM198010023031409","article-title":"Familial hypocalciuric hypercalcemia","volume":"303","author":"Marx","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2012.11.003_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jocd.2012.11.003_bib41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3476(47)80079-4","article-title":"Hypercalcemia and idiopathic hyperplasia of parathyroid glands in infant","volume":"30","author":"Pratt","year":"1947","journal-title":"J Pediatr"},{"key":"10.1016\/j.jocd.2012.11.003_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM196403052701001","article-title":"Neonatal familial primary hyperparathyroidism","volume":"270","author":"Hillman","year":"1964","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jocd.2012.11.003_bib43","first-page":"529","article-title":"Acute hyperparathyroidism in primary parathyroid hyperplasia","volume":"22","author":"M\u00fchlethaler","year":"1967","journal-title":"Helv Paediatr Acta"},{"key":"10.1016\/j.jocd.2012.11.003_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jocd.2012.11.003_bib45","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI117062","article-title":"Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism: effects of mutant gene dosage on phenotype","volume":"93","author":"Pollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocd.2012.11.003_bib46","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jocd.2012.11.003_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/0003-4819-92-3-351","article-title":"Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration","volume":"92","author":"Marx","year":"1980","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jocd.2012.11.003_bib48","first-page":"2042","article-title":"Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor","volume":"85","author":"Carling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.003_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","article-title":"Parathyroid surgery in familial hyperparathyroid disorders","volume":"257","author":"Carling","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.jocd.2012.11.003_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-49-4-829","article-title":"Hereditary hyperparathyroidism associated with recurrent pancreatitis","volume":"49","author":"Jackson","year":"1958","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.jocd.2012.11.003_bib51","first-page":"4204","article-title":"Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas","volume":"81","author":"Teh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.003_bib52","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1210\/jc.2003-031016","article-title":"Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene","volume":"89","author":"Cavaco","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.jocd.2012.11.003_bib53","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2012.11.003_bib54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2796.2003.01168.x","article-title":"Hyperparathyroidism-jaw tumour syndrome","volume":"253","author":"Chen","year":"2003","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.jocd.2012.11.003_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/qjmed\/94.4.213","article-title":"The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred","volume":"94","author":"Cavaco","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.jocd.2012.11.003_bib56","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.003_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","article-title":"Parafibromin\u2014functional insights","volume":"266","author":"Newey","year":"2009","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.003_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","article-title":"Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome","volume":"257","author":"Bradley","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.jocd.2012.11.003_bib59","first-page":"1485","article-title":"Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer","volume":"77","author":"Wassif","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.003_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds","volume":"81","author":"Simonds","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.jocd.2012.11.003_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s002689900188","article-title":"Familial hyperparathyroidism without multiple endocrine neoplasia","volume":"21","author":"Huang","year":"1997","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.jocd.2012.11.003_bib62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/eje.0.1450155","article-title":"Familial isolated primary hyperparathyroidism\u2014a multiple endocrine neoplasia type 1 variant?","volume":"145","author":"Miedlich","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jocd.2012.11.003_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","article-title":"Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications","volume":"41","author":"Warner","year":"2004","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.jocd.2012.11.003_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ncpendmet0718","article-title":"Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene","volume":"4","author":"Hannan","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.003_bib65","first-page":"2114","article-title":"Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families","volume":"83","author":"Teh","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jocd.2012.11.003_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1530\/eje.0.1470313","article-title":"Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism","volume":"147","author":"Villablanca","year":"2002","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:38:31Z","timestamp":1761082711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695012002326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1094695012002326"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2012.11.003","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary Hyperparathyroidism Syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2012.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}